Searching for perturbed biological pathways and genes through analyzing the expression profile changes in osteoclasts...

Area of Science:

• Genomics
• Systems Biology
• Pharmacology

Background:

• Osteoporosis is a significant skeletal disorder.
• Bisphosphonates are commonly prescribed for osteoporosis treatment.
• The precise molecular mechanisms underlying bisphosphonate action and osteoporosis pathogenesis require further elucidation.

Purpose of the Study:

• To identify critical biological pathways and key genes associated with osteoporosis.
• To investigate the impact of bisphosphonate treatment on these pathways and genes.
• To enhance understanding of osteoporosis mechanisms and therapeutic responses.

Main Methods:

• Downloaded human pathway data and osteoclast expression data from public databases.
• Utilized Gibbs sampling and Markov chain analysis to identify disturbed pathways and hub genes.
• Set an adjusted probability threshold (α ≥ 0.75) to define significance.

Main Results:

• Identified four significantly disturbed pathways: Maturity onset diabetes of the young, Olfactory transduction, Cyanoamino acid metabolism, and Taurine and hypotaurine metabolism.
• Identified two hub genes: OR2A4 and NKX2-2, with α ≥ 0.75.
• Observed downregulation of these pathways and genes in osteoclasts treated with bisphosphonates.

Conclusions:

• Four disturbed pathways and two hub genes critical to osteoporosis were identified.
• The identified pathways and genes were downregulated by bisphosphonate treatment.
• These findings contribute to a deeper understanding of osteoporosis pathogenesis and bisphosphonate treatment efficacy.